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Sex diﬀ   erences have been noted in the prevalence, 
incidence, and severity of osteoarthritis (OA) for many 
years [1-3]. Th   e incidence of knee, hip, and hand OA is 
higher in women than men and in women increases 
dramati  cally around the time of menopause [3,4], 
prompting many investigations into the roles of estrogen 
and other hormones as possible explanatory factors. 
Results of clinical and epidemiologic studies have been 
conﬂ  icting [5-7], with some showing a protective eﬀ  ect 
for estrogen or hormone replacement therapy (HRT) on 
radiographic knee and hip OA [8,9] or progression to 
joint replacement [10] but no eﬀ  ect on joint symptoms 
[11]. Diﬀ   erences in study results can be ascribed to 
diﬀ  erences in (a) study populations and study designs; (b) 
distribution of, or confounding by, other risk factors such 
as age, race/ethnicity, body mass index (BMI), and smok-
ing; and (c) joints aﬀ  ected by OA and deﬁ  nitions used to 
deﬁ  ne OA [3] and statistical method  ology. A recent sys-
tem  atic review of 17 studies illustrates this point. Th  ere 
was no clear association between sex hormones and 
hand, knee, or hip OA in women, but study heterogeneity 
precluded combining them into a single analysis [6]. For 
example, radiographic OA can be deﬁ   ned by overall 
radiographic scoring, such as the Kellgren-Lawrence 
system (grades 0 to 4) [12], or by individual radiographic 
features, such as osteophytes or joint space narrowing 
[13]. Other deﬁ   nitions may incor  porate joint-speciﬁ  c 
symptoms with or without accom  pany  ing radiographic 
OA. With these multiple methods of examining sex 
diﬀ  erences in OA, it is no wonder that the issue is far 
from settled.
One way to examine the basis of sex diﬀ  erences in OA 
is to examine sex diﬀ  erences in the individual compo-
nents of the joint through magnetic resonance imaging 
(MRI) and joint metabolism biomarkers. Structural 
features of OA can be examined using overall grading 
[14] or, more commonly, by individual features, such as 
cartilage thickness or volume, synovial hypertrophy and 
eﬀ  usion, bone marrow lesions, or meniscal pathology. 
Additionally, rather than studying individuals who 
already have OA (that is, prevalent disease) as is commonly 
done, studying unaﬀ  ected individuals followed prospec-
tively may inform this question better since this approach 
avoids the question of temporality inherent in cross-
sectional studies of prevalent disease, allows an assess-
ment of the predictive value of speciﬁ  c ﬁ  ndings for the 
development of OA, and potentially provides an oppor-
tunity for primary prevention and early interven  tion. 
Th   is entails the examination of intrinsic characteristics of 
younger healthy men and women before they develop 
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© 2010 BioMed Central LtdOA or even the examination of normal children. With 
increasing attention to risk factors for multiple diseases 
across the life course [15,16], this approach could expose 
potential mechanisms behind sex diﬀ  erences in OA and 
identify high-risk people in advance of disease.
Reviews of the epidemiology of sex diﬀ  erences in OA 
have recently been published [5-7,17]. Th  is review will 
instead highlight novel study designs or studies of un-
aﬀ  ected and younger individuals, including children, to 
focus on sex diﬀ  erences in (a) structural joint compo-
nents using MRI and (b) biomarkers of joint metabolism.
Insight into sex diff  erences in structural joint 
components using magnetic resonance imaging
Cartilage thickness, volume, and defects
Since men and women vary in body size, one might 
assume that men have greater cartilage volume. Cicuttini 
and colleagues [18] were among the ﬁ  rst teams to test 
this hypothesis in knee cartilage volume using MRI. In 17 
Australian men and 11 women who had normal knee 
radiographs and who were having knee MRI because of 
knee pain of less than 3 months in duration, men had 
larger femoral and patellar cartilage volumes than 
women, independently of age, height, weight, and bone 
volume. Sex diﬀ  erences in patellar cartilage volume were 
magniﬁ  ed with increasing age [18]. In a study of nine 
healthy German men and nine women in their early 20s 
without a history of athletic or heavy physical activity, 
Faber and colleagues [19] conﬁ   rmed lower cartilage 
volumes in women than men and showed that this sex 
diﬀ  erence was related primarily to diﬀ  erences in joint 
surface area or bone size rather than cartilage thickness, 
where diﬀ   erences were less pronounced and not 
statistically signiﬁ  cant.
Otterness and Eckstein [20] hypothesized that smaller 
joint surfaces in women might explain sex diﬀ  erences in 
knee OA because of higher articular pressures with 
smaller surface area. Using healthy men and women, the 
authors conﬁ  rmed that men have greater knee sub  chon-
dral bone area, cartilage thickness, and cartilage volume 
compared with women, after adjustment for height and 
weight [20]. Estimated tibial or patellar pressures, using 
the metric of body weight/joint surface area, however, 
were equivalent in men and women, suggesting that 
smaller joint surfaces in women were not a likely explana-
tion for sex diﬀ  erences in knee OA [20].
Th   ese authors found that total subchondral bone area 
and cartilage volume were strongly associated in young 
healthy men and women. However, while cartilage 
volume and bone area were strongly related to height in 
women, their associations with height in men were weak 
and inconsistent, leading the authors to suggest the 
possibility that diﬀ  erent factors are responsible for bone 
and cartilage growth in men and women [21].
Longitudinally, Australian women have been shown to 
have a higher rate of cartilage loss than men [22,23], 
whereas men may have a higher rate of cartilage loss than 
women in studies in the US [24,25]. In 135 Australian 
men and 190 women from 26 to 61 years old (mean age 
of 45 years), Ding and colleagues [22] reported that, over 
an average of 2.3 years, women had a higher annual rate 
of cartilage volume loss than men in all knee 
compartments, although only tibial cartilage loss was 
statistically signiﬁ  cantly  diﬀ   erent by sex. Th  ese sex 
diﬀ  erences ﬁ  rst appeared at age 40 and increased with 
age [22]. Importantly, there were no signiﬁ  cant  sex 
diﬀ  erences in the crude annual percentage change or in 
the annual percentage change adjusted for age, BMI, and 
oﬀ  spring/control status in cartilage volume in any plates; 
sex diﬀ  erences were evident only after further adjustment 
for baseline cartilage volume and bone size, and this 
could have inﬂ  ated the diﬀ  erence. Th  e composition of 
this con  venience sample was intriguing; the sample 
consisted of oﬀ  spring of people who had undergone knee 
arthroplasty for knee OA and the rest were from the 
general popu  lation. Interestingly, the magnitude of 
cartilage loss was higher in oﬀ  spring than the general 
population, suggest  ing a high risk for the development of 
cartilage loss and presumably, later, for the development 
of knee OA [22]. Women were also three times more 
likely than men to have increases in tibial cartilage 
defects over time [22,23].
A diﬀ  erent result was obtained from the Osteoarthritis 
Initiative (OAI) [24,25], an ongoing multi-center study in 
which a 3-Tesla MRI of the knee is obtained annually in 
approximately 4,800 individuals from 45 to 79 years old 
at baseline either with symptomatic radiographic knee 
OA (progression cohort) or with risk factors to develop 
knee OA (incidence cohort) [26]. An early study of the 
progression subcohort evaluated individuals (79 women 
and 77 men, mean age of 61 years) with frequent knee 
symptoms and radiographic knee OA in at least one 
knee. After 1 year, modest cartilage thick  ness loss 
occurred, more in the medial compartment than in the 
lateral, more in the medial femur than in the medial tibia, 
and more in the lateral tibia than in the lateral femur. 
Th  ere were no statistically signiﬁ  cant diﬀ  er  ences in the 
rate of change of cartilage volume or thick  ness by age, 
sex, BMI, frequent symptoms, or radio  graphic Kellgren-
Lawrence grade [24]. In the OAI, in contrast to the 
Australian studies, there was a non-statistically 
signiﬁ  cant trend for men to have a greater rate of change 
in cartilage volume and thickness than women. Th  e 
authors conceded that statistical power was limited, the 
period of observation was short, and only one knee 
(which may not have been the symptomatic knee) for 
imaging with Coronal FLASHwe (fast low angle shot with 
water excitation) was studied [24,25]. When only some 
Maleki-Fischbach and Jordan Arthritis Research & Therapy 2010, 12:212 
http://arthritis-research.com/content/12/4/212
Page 2 of 8plates demonstrate diﬀ  erences, it is unclear whether this 
illuminates potential mechanisms, perhaps biomecha-
nical, or represents a chance occurrence. None of these 
studies accounted for multiple comparisons inherent in 
the analysis of detailed MRI data, and it remains to be 
seen whether diﬀ   erences will be replicated in larger 
samples in which such multiple comparison testing is 
considered.
Hormonal associations with cartilage metrics by magnetic 
resonance imaging
Sex hormones and HRT after menopause have received 
considerable attention in the assessment of radiographic 
knee and hip OA, symptomatic OA, and joint replace-
ment but with conﬂ  icting results [8-11,27-29]. Using MRI 
outcomes, Wluka and colleagues [30] reported that 
healthy women who had no knee pain and who were 
taking HRT had greater knee cartilage volume than 
women not on HRT, suggesting a chondroprotective role 
for HRT. Such promising cross-sectional results were not 
borne out on longitudinal assessment [31]. Serum testos-
terone levels in such healthy women were not associated 
with cartilage thickness, cartilage defects, bone surface 
area, or large bone marrow lesions [32].
In healthy men without knee pain, on the other hand, 
cartilage volume was directly related to serum testos-
terone levels, but testosterone was not associated with 
change in cartilage volume [33]. Th  e authors of these 
studies acknowledged that serum measures of androgens 
may not accurately reﬂ  ect levels and activity at the site of 
interest, and so the implication of these ﬁ  ndings  is 
unclear [32,33].
Leptin, a 16-kDa non-glycosylated hormone encoded 
by the obese gene and secreted by adipocytes, osteo-
blasts, and chondrocytes, has received some attention in 
OA and may be related to sex diﬀ  erences in OA [34]. 
Leptin is elevated in OA cartilage and osteophytes 
[35,36], and higher concentrations have been found in 
synovial ﬂ  uid in OA [37]. Women and those with higher 
BMI have higher leptin levels as well [38]. Ding and 
colleagues [39] evaluated cross-sectional associations 
between serum leptin levels and cartilage volume and 
carti  lage defects in a subsample (n = 190, 48% were 
women, and mean age was 63 years) of the Tasmanian 
Older Adult Cohort, a population-based cohort of 
incidence and progression of OA and osteoporosis. In 
multi-variable analyses controlling for sex, age, BMI, 
smoking, radiographic knee OA, bone size, and other 
diseases (rheumatoid arthritis, cardiovascular disease, 
asthma, and diabetes), log-transformed leptin levels were 
signiﬁ  cantly associated with knee cartilage volume but 
not with cartilage defects. Importantly, for the purposes 
of this review on sex diﬀ   erences in cartilage volume, 
leptin levels partially mediated the relationship between 
sex and cartilage volume, with a decrease in the R2 of the 
multi-variable model from 51% to 30% with additional 
adjustment for leptin levels [39]. Leptin did not mediate 
sex associations with cartilage defects. Th   ese studies suggest 
that leptin may mediate some sex diﬀ  erences in OA.
Imaging of cartilage in children
In keeping with the premise that sex diﬀ  erences  in 
cartilage may be intrinsic or present many years in 
advance of OA onset, Jones and colleagues [40] per-
formed a cross-sectional study of knee cartilage thickness 
and volume and bone surface area in 49 boys and 43 girls 
from 9 to 18 years old. One might expect boys to have 
larger cartilage volume than girls, and the authors 
controlled for multiple factors – such as age, BMI, bone 
area, number and type of sports participated in, vigorous 
physical activity, and lower limb muscle strength – that 
could inﬂ   uence these relationships. After adjustment, 
boys had greater cartilage thickness and volume than 
girls in all Tanner stages, with sex accounting for 20% of 
patellar volume, 26% of medial tibial volume, and 8% of 
lateral tibial cartilage volume. Th   ere was no diﬀ  erence in 
cartilage volume between pre- and post-menarchical girls.
Although many factors are related to the sex diﬀ  erence 
in cartilage parameters, these results imply that sex 
diﬀ  erences exist from early stages in the life course and 
that OA is likely determined or at least inﬂ  uenced by 
events in early life, even in the absence of joint injury. 
Th  is principle is consistent with murine mesenchymal 
stem cell studies in which cells from male animals 
produced a ‘richer extra-cellular matrix’ [41] and larger 
culture pellet than cells from female animals. Further-
more, the regenerative potential of male cells was superior 
to that of female cells, with male cells providing better 
cartilage repair in nude mice than female cells did [41]. 
Koelling and Miosge [42] recently described sex diﬀ  er-
ences in chondrogenic pro  geni  tor cells in cartilage from 
men and women under  going knee joint replacement for 
OA. Th   e authors observed that gene expression patterns 
diﬀ  ered by sex for ESR-1 and -2 genes, the transcription 
factor Sox9, and types I and II collagen [42]. Th  ere  were 
also sex diﬀ  er  ences in the eﬀ  ect of sex hormones upon 
collagen II gene expression and in regulatory eﬀ  ects 
independently of Sox9 and Runx2. Th   ese studies showed 
that sex diﬀ  er  ences in cartilage occur from early develop-
ment and persist through end-stage OA, suggesting that 
therapies might need to be tailored to men and women.
Meniscus and ligaments
Girls and women have diﬀ  erent biomechanics, gait, and 
structural and morphometric properties of tendons and 
ligaments than boys and men [43-47]. It is likely that 
these intrinsic diﬀ   erences contribute to the increased 
frequency of ligamentous injury in young female athletes 
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the sex disparity in OA in later life is unclear, and 
surprisingly little attention has been devoted to sex 
diﬀ  erences in these structures using MRI in adults [48]. 
Fayad and colleagues [48] described diﬀ  erences  in 
anterior cruciate ligament bundle volumes in 33 men and 
30 women (mean age of 43, range of 15 to 70 years) refer-
red for clinical MRI. Although there was a sex diﬀ  erence 
in anterior cruciate ligament volume, this was explained 
entirely by diﬀ  erences in height [48].
In a study that was mostly of asymptomatic individuals 
in Australia, women were over four times more likely 
than men to have meniscal tears by 1.5-Tesla MRI [49]. In 
contrast, 32% of the men and 19% of the women in the 
Framingham cohort (n = 991, 57% were women, and 
mean age was 62.3 years) had meniscal tears or destruc-
tion by 1.5-Tesla MRI, with the prevalence in both sexes 
increasing with age [50]. In a study of women who were 
older than 40 years of age, had knee OA, and had been 
screened into a clinical trial for OA, meniscal tears were 
present in 73%, and not surprisingly, these were asso-
ciated with signiﬁ  cant impairment in walking endurance 
and balance after OA duration, symp  toms, disability, 
body composition, and relevant clinical characteristics 
were controlled for [51].
Finally, Stehling and colleagues [52] recently reported 
associations between various knee lesions on 3-Tesla 
MRI and physical activity in 236 individuals from 45 to 
55 years old in the asymptomatic incidence subcohort of 
the OAI. Although assessment of sex diﬀ  erences in MRI 
features was not the purpose of the paper, ligamentous 
abnormalities were more likely in men than women (23% 
versus 12.5%) and meniscal lesions were more common 
and more likely to be severe in men (54% versus 42%). In 
contrast, cartilage abnormalities were slightly more 
common in women (76.5% versus 72%) but full-thickness 
cartilage defects were more common in men (24% versus 
14.7%). Th   e prevalence of some features was higher than 
in previous studies, especially since these were asymp-
tomatic individuals, and this is likely related to increased 
sensitivity from the stronger magnetic ﬁ  eld used in this 
study.
Th   ese few studies show widely disparate results, likely 
because of diﬀ  erent study designs, statistical power, MRI 
protocols, and study populations varying by geographic 
location, age distribution, clinical characteristics, and 
source of participants. Th   ese factors make interpretation 
impossible and mandate further research to determine 
whether sex diﬀ  erences exist in these parameters and to 
understand the mechanisms behind such diﬀ  erences.
Bone marrow lesions and bone cysts
In OA, bone marrow lesions are common and are asso-
ciated with knee OA progression and pain [53-55]. In the 
ﬁ  rst description of these in healthy men and women free 
of knee pain, Davies-Tuck and colleagues [56] reported 
that sex was not associated with the presence, develop-
ment, or persistence of bone marrow lesions on knee 
1.5-Tesla MRI over 2 years in the Melbourne Collabora-
tive Cohort Study. Studies evaluating the coexistence of 
these lesions with cartilage loss, meniscal abnormalities, 
and bone cysts have for the most part not focused on sex 
diﬀ   erences in these relationships [54]. Tanamas and 
colleagues [57] reported that bone cysts were more 
common in men than women in a study of the relation-
ship between bone cysts and subsequent knee replace-
ment 4 years later, but further investigation into the role 
of sex diﬀ  erences in these lesions was not conducted.
Sex diff  erences in biomarkers of joint metabolism
Another way to understand the etiopathogenesis of sex 
diﬀ  erences in OA is to examine factors representative of 
joint metabolism. In order for synovial and systemically 
measured biomarkers to be used to identify high-risk 
individuals before OA occurs or before it becomes 
clinically manifest, normative data in various popula-
tions, including subgroups by sex, are required. For some 
markers, such as type I collagen N-telopeptide (NTX-I) 
and osteocalcin (which are markers of bone resorption 
and synthesis, respectively), much is known about sex 
diﬀ  erences and (within women) the eﬀ  ects of menopause 
and HRT, but for other markers, much less is known. 
Reports using markers for OA frequently control for sex 
but do not describe sex diﬀ  erences speciﬁ  cally [58,59]. 
Critically important is knowing what other factors – such 
as the body burden of OA, BMI, hormonal status, or 
other medical conditions – might confound a sex diﬀ  er-
ence in a speciﬁ  c marker, especially when considering a 
biomarker that is ubiquitous in connective tissue, such as 
hyaluronan (HA) [60]. Th  is report will examine sex 
diﬀ   erences in several of the more frequently used 
markers in OA, targeting presumably diﬀ  erent processes.
Type II collagen degradation
Mouritzen and colleagues [61] described a marker of 
type II collagen turnover, cartilage-derived urinary 
collagen type II C-telopeptide degradation products 
(CTX-II), in 615 healthy men and women from 20 to 87 
years old. Levels were similar in men and women from 30 
to 45 years old and then increased in both men and 
women, with the levels of women being slightly higher 
than those of men (Figure 1 from [61]). Levels were also 
higher in post-menopausal women compared with pre-
menopausal women; and in post-menopausal women, 
those taking HRT had lower levels than those not taking 
HRT. Furthermore, those taking HRT for a longer time 
had lower levels than those taking HRT for a shorter 
duration [61].
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C2C, a marker of intra-helical type II collagen cleavage, 
in 69 Japanese men (mean age of 43 years) and 71 
Japanese women (mean age of 44 years; 34% of the 
women were post-menopausal) who did not have joint or 
spinal pain or major medical conditions and who were 
not taking medications aﬀ   ecting bone metabolism. In 
individuals younger than 50 years, C2C was higher in 
women than men, and the reverse was the case in those 
older than 50 years. C2C levels were unrelated to meno-
pausal status. Since CTX-II and C2C are both markers of 
type II collagen cleavage, why would results be diﬀ  erent 
for each marker? Th  e authors propose that diﬀ  erences 
might be because the markers are the product of diﬀ  erent 
areas in the type II collagen molecule that get degraded, 
and the markers’ diﬀ  erent locations in the joint [62].
Matrix protein degradation
Cartilage oligomeric matrix protein (COMP) is a 64-kDa 
pentameric matrix protein found in most joint tissues, 
including cartilage, bone, tendon, ligament, synovium, 
and vascular smooth muscle. It is elevated in OA [63-67], 
predicts incidence of radiographic hip OA [65,66], and is 
higher with increasing body burden of OA-aﬀ  ected large 
joints [63,64,67]. Clark and colleagues [63] described the 
ﬁ  rst and largest population-based assessment of serum 
COMP using competitive enzyme-linked immunosorbent 
assay (ELISA) with monoclonal antibody 17-C10 in 
Caucasians in the Johnston County Osteoarthritis Project 
(JoCo OA). COMP increased with age and was higher in 
OA than controls but did not signiﬁ  cantly vary by sex. 
Later, in the same study population, Jordan and colleagues 
[64] used a sandwich ELISA with monoclonal antibodies 
16-F12 and 17-C10 and reported that serum COMP 
levels among Caucasians but not African-Americans were 
higher in men than women (Figure 1, page 679 from [64]). 
Serum COMP levels were associated with a 30% increased 
risk of hip OA development in older Caucasian women in 
the Study of Osteoporotic Fractures [65]; those in the 
highest three quartiles of change in this marker had a 
ﬁ  vefold increase in the risk of incident hip OA compared 
with those in the lowest quartile of change [66]. No direct 
comparison of these results to men was possible in this 
study. No further speciﬁ  c evaluations of sex diﬀ  erences in 
COMP in relation to OA have been conducted.
Synovial infl  ammation
HA is a ubiquitous glycosaminoglycan formed from 
alternating units of glucosamine and glucuronic acid. It is 
a constituent of synovium and cartilage and is indicative 
of synovial inﬂ  ammation and has been shown to be an 
important marker of systemic burden of OA in women 
[60]. Elliott and colleagues [60] reported that men had 
higher serum HA levels than women did in the JoCo OA; 
importantly, this eﬀ  ect was independent of diﬀ  erences in 
age, race/ethnicity, OA burden in knees or hips, BMI, or 
comorbidities. Th  is was conﬁ  rmed in a recent study of 
mitochondrial DNA haplogroups and their eﬀ  ect upon 
serum levels of multiple biomarkers in Spanish patients 
with knee and hip OA [68].
Systemic and synovial cytokines
Pagura and colleagues [69] examined systemic and 
synovial measures of cytokines (interleukin [IL]-1-alpha/
beta, tumor necrosis factor-alpha, and IL-6) and growth 
factors (insulin-like growth factor-1 [IGF-1], transform  ing 
growth factor-beta [TGF-β], and interleukin 1 receptor 
antagonist [IRAP]) in a small study of 9 Canadian men 
and 8 women awaiting knee replacement and compared 
them with 21 age- and sex-matched controls recruited 
from the local community. Men had higher levels of 
serum and synovial IGF-1, but there were no sex diﬀ  er-
ences in any of the other markers. However, the very 
small sample size and undetectable levels of cytokines, 
except for IL-6, render the impact of this study 
questionable [69].
Growth factor
Lastly, in the largest study of serum TGF-β to date, 
Nelson and colleagues [70] reported that this marker was 
higher in women than men in the JoCo OA and that the 
associations between this marker and prevalent 
radiographic knee and hip OA, osteophytes, and joint 
space narrowing were similar in men and women. A 
single measure of this marker was unable to predict 
incidence or progression of radiographic knee or hip OA, 
osteophytes, or joint space narrowing in either men or 
women [71].
Summary and suggestions for future research
Sex diﬀ  erences in prevalence, incidence, and severity of 
radiographic and clinical OA have been described, but 
speciﬁ  c examination of sex diﬀ  erences in MRI biomarkers 
and in biomarkers of joint metabolism are few, and 
results vary considerably. Despite some variation across 
study designs and study populations, women appear to 
have a thinner and more reduced volume of cartilage in 
the knee than men, and this may occur from early 
childhood. Th  e relationship between cartilage volume 
and bone area cannot be ignored in analyses of these 
issues. Whether women have a more accelerated rate of 
cartilage volume loss than men remains unsettled. Few 
data exist on sex diﬀ  erences in other tissues of the knee 
by MRI and in systemic biomarkers of joint metabolism, 
and those that do exist frequently vary in the assessment 
of potential mediators of sex diﬀ  erences.
Most studies of OA have been limited to Caucasians. 
Future studies should examine these relationships in 
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delve into aspects that are likely to shed light upon 
mechanisms behind sex diﬀ  erences. In particular, studies 
of imaging and biochemical biomarkers, rather than 
merely control for sex, should speciﬁ  cally  examine 
whether sex diﬀ   erences exist in that biomarker. 
Additionally, studies should establish whether risk factors 
act similarly or diﬀ  erently in men and women, with an 
eye to deter  mining whether sex-speciﬁ  c therapies make 
sense. Studies of mesenchymal stem cells, outlined above 
[41], suggest that this may not be such a far-fetched idea.
Another question deserving attention is whether 
height, weight, and bone area can adequately serve as 
proxies for body size, a crucial issue in understanding sex 
diﬀ  erences in imaging biomarkers. Future studies might 
evaluate other potential proxies, such as height × weight 
and others [19], in relation to sex diﬀ  erences in joint 
structures by MRI. Finally, sex diﬀ  erences in the genetics 
of OA have been noted for multiple genes and joint sites 
[72-74], and studies of sex diﬀ  erences in these genetic 
eﬀ   ects should dovetail with those using advanced 
imaging and biochemical biomarkers for maximal 
mechanistic insight.
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